Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70–100 mg/dL in Taiwan-Reference-Cited by-同舟云学术

Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70–100 mg/dL in Taiwan

Published:2020-05 Issue:5 Volume:119 Page:907-916
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Lin Fang-Ju,Shyu Kou-Gi,Hsieh I-Chang,Huey-Herng Sheu Wayne,Tu Shih-Te,Yeh Shoou-Jeng,Chen Chin-I,Lu Kuo-Cheng,Wu Chia-Chao,Shau Wen-Yi,Inocencio Timothy J.,Wen Yao-Chun,Yeh Hung-I

Funder

Pfizer Ltd

Pfizer Ltd.

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation;Smith;Circulation,2011

2. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American heart association task force on practice guidelines;Eckel;Circulation,2014

3. 2016 European Guidelines on cardiovascular disease prevention in clinical practice

4. Recent update to the US cholesterol treatment guidelines: a comparison with international guidelines;Nayor;Circulation,2016

5. 2017 Taiwan lipid guidelines for high risk patients;Li;J Formos Med Assoc,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and associated factors of non-adherence to antihyperlipidemic medication: a nationwide cross sectional survey in Pakistan;Scientific Reports;2024-09-04

2. Pharmacoeconomic Evaluation of Conservative and Interventional Management in patients with Coronary Artery Disease: Real World Data;Research Journal of Pharmacy and Technology;2024-05-15

3. Cost–utility analysis of using high-intensity statin among post-hospitalized acute coronary syndrome patients;The Egyptian Heart Journal;2024-04-14

4. Cardiovascular Event Recurrence and Costs after First Myocardial Infarction, Ischemic Stroke, or Intracerebral Hemorrhage in Taiwan;ACTA CARDIOL SIN;2023

5. The cost-effectiveness and cost-utility of statin drug for the treatment of patients with cardiovascular disease, a systematic review;International Journal of Preventive Medicine;2021